Synonyms:
Status: Phase 1
Entry Type: Antibody
Molecule Category: UKNOWN
UNII: Y6M3205516

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Receptor tyrosine-protein kinase erbB-3 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 1 D002289 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL3707404
FDA SRS Y6M3205516